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The life cycle of Leishmania includes sequential development of invertebrate-
stage promastigotes from a noninfective to an infective stage (1-4) . This can be
demonstrated for promastigotes growing both within the phlebotomine midgut
and within axenic cultures . Promastigotes grown axenically to log stage are
minimally infective for mice and are incapable of establishing intracellular
infection within macrophages . In contrast, parasites grown to the stationary
phase ofgrowth demonstrate increased infectivity for cells and enhanced viru-
lence for mice . The developmental changes occurring during transition from
the noninfective log form to the infective metacyclic stationary phase form ofL.
major are current areas of study . Sacks et al . (5) have demonstrated that concen-
trations of peanut agglutinin (PNA)' that agglutinate 100% of organisms from
log-phase cultures fail to agglutinate metacyclic promastigotes found within
stationary cultures, and that the loss of agglutination with PNA can be used as
the basis for purification of infective promastigotes (PNA-) from culture . This
difference in PNA agglutinability reflects developmental modification of aprom-
inent surface lipophosphoglycan (LPG) (6) previously shown by Handman et al .
(7) to be shed from the parasite . HandmanandGoding (8) have alsodemonstrated
that the LPG, also termed excreted factor, is necessary for the attachment of the
promastigote tomacrophages (8), and thatimmunization ofmice with this antigen
confers protection to subsequent challenge (9) . Studies by Sacks and da Silva (10)
have shown that the developmentally regulated modification ofthe LPG involves
acquisition of a novel carbohydrate determinant and that this modification
appears to be a definitive marker for metacyclogenesis and a prerequisite for
parasite infectivity in mice . Nonetheless, the mechanism by which this develop-
mental change renders the parasite infective has not been defined .
Address correspondence to Dr. Stephen M. Puentes, National Institute of Allergy and Infectious
Diseases, Laboratory of Parasitic Diseases, Building 5, Room 114, 9000 Rockville Pike, Bethesda,
MD 20892 .
'Abbreviations used in this paper. C8D, C8-deficient serum ; LPG, lipophosphoglycan ; LOG,
noninfective log-phase growth promastigotes ; LS, lysis solution ; NPGB, p-nitrophenyl-o-guanidino
benzoate; PNA, peanut agglutinin .
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Recent studies have focused attention on the interaction of the complement
system with Leishmania. Franke et al. (11) have demonstrated that stationary
phase promastigotes of various Leishmania species are relatively serum resistant,
in comparison to the exquisite serum sensitivity demonstrated for promastigotes
in the logphase ofgrowth. Thus, Leishmaniaare similartoother trypanosomatids
(12, 13), in that the infective form ofthe parasite within the vector ispreadapted
to a complement-resistant form before it comes in contact with the hostile
environment of the vertebrate host complement system. However, the mecha-
nism of this preadaptation in Leishmania major is poorly understood. There is
recent evidence to suggest that not only are infective promastigotes resistant to
killing by complement, but their interaction with the complement system may in
fact promote their intracellular survival. Monocyte and macrophage receptors
for the third component of complement are critical for Leishmania infectivity.
Blackwell et al. (14) demonstrated that mAbs to the complement receptor CR3,
which recognizes the iC3b fragment of complement, inhibited attachment of
unfractionated Leishmania donovani promastigotes by nearly 80%. This group
has suggested that complement components produced locally by macrophages
are sufficient to opsonize the promastigote for complement receptor-mediated
uptake (14), and have shown that stationary promastigotes ofL. donovani bear
more C3 on their surface (15). Mosser and Edelson (16) have extended the
finding ofBlackwell et al. (14) to L. major, and have shown that attachment and
uptake are inhibited by 63% with anti-CR3 mAb and that intracellular survival
can be enhanced by C3 opsonization (17).
Given thecritical role thatthe complement system appears toplay in theability
of Leishmania promastigotes to initiate infection, it was of obvious interest to
compare complementbinding by infective and noninfective developmental stages
of these parasites. We have therefore undertaken a detailed analysis ofthe form
of C3 on the surface ofnoninfective log-phase growth promastigotes (LOG) and
metacyclic promastigotes of (PNA-) L. major, on the C3 acceptor molecules on
these two stages, and on the processing of bound C3. Our results indicate that
LOGand PNA- promastigotesactivate complement throughdifferent pathways,
but both forms bear predominantly C3b, which is associated with the LPG.
Extensive release of C3b occurs from LOG but not PNA- promastigotes due to
a proteolytic cleavage event. These results correlate with ongoing studies in our
laboratory examining the complement receptors and ligands involved in cell
attachment and invasion by L. major.
Materials and Methods
Parasites.
￿
L. major Friedlin strain NIH, clone VI, (World Health Organization desig-
nation MHOM/IL/80/Friedlin) promastigotes were grown at 26°C in Grace's insect
medium (Gibco Laboratories, GrandIsland, NY)containing20% (vol/vol)heat-inactivated
FCS, 12 mM Hepes, 20 MM L-glutamine, 1,000 U/ml penicillin, and 50 Ag/ml strepto-
mycin. LOG were harvestedwhen growth was at 0.5-1 x 107 parasites/ml. Promastigotes
not agglutinated by peanut agglutinin (PNA-) were harvested from a 5-6-d-old stationary
phase culture (4-5 x 107 parasites/ml), as previously described (5). Briefly, PNA (Vector
Laboratories, Inc., Burlingame, CA) was added to washed stationary growthpromastigotes
to a final concentration of 50 jug/ml. The PNA agglutinated parasites were separated
from PNA nonagglutinated (PNA-) parasites by centrifugation at 150 g for 5 min at room
temperature and were washed twice in HBSS2+ (see below). LOG and PNA- promastigotesPUENTES ET AL.
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were washed three times in HBSS2+, collected by centrifugation at 5,000 g for 20 min at
room temperature, and maintained at room temperature until used in experiments.
Buffers and Inhibitors.
￿
HBSS (Gibco Laboratories) containing 1 MM MgC12 and 0.15
mM CaCl2 (HBSS2+) was used for washing parasites and preparing serum dilutions.
Protease inhibitors used throughout experiments were p-nitrophenyl-o-guanidino ben-
zoate (NPGB) (Calbiochem-Behring Corp., La Jolla, CA) at a final concentration of 100
,,M and leupeptin (Boehringer Mannheim Biochemicals, Indianapolis, IN) at a final
concentration of 25,ug/ml.
Serum.
￿
A pool of normal human serum (PNHS) was prepared from seven healthy
donors. Serum deficient in complement component 8 (C8D) was obtained from a single
donor. All serum aliquots were frozen at -70°C to maintain functional complement
activity. Some samples of serum were heated to 56 °C for 30 min to inactivate complement.
Complement Components.
￿
Human C3 was purified using minor modifications of the
procedure previously described by Hammer et al . (18). Functionally active C3 was
iodinated using Iodo-beads (Pierce Chemical Co., Rockford, IL) and '25I-Na (Amersham
Corp., Arlington Heights, IL) to a sp act of 2.0-8.0 X 105 cpm/ag of total C3 protein.
The functional hemolytic activity of the " 25I-C3 was ^-25,000-50,000 C3 hemolytic
Units/ml (60-75 C3 hemolytic U/wg).
Antibodies and Solid-phase Immunoabsorbants. Polyvalent goat anti-human C3 was
prepared and the IgG fraction isolated using a two-step octanoic acid/DEAE-cellulose
procedure previously described (18). Goat IgG anti-human C3 was coupled to Sepharose
4B (Pharmacia Fine Chemicals, Piscataway, NJ) as previously described by Hammer et al.
(18). Anti-human C3 antibody coupled to Sepharose 4B (anti-C3) recognized determi-
nants on C3, C3b, iC3b, C3c, and C3dg. A rabbit polyclonal antibody directed against L.
majorgp63 was kindly provided by Dr. Clement Bordier (Institut de Biochimie, Universite
de Lausanne, Switzerland). An mAb against the LPG from LOG culture supernatants
(79-3) was a gift from David Snary, Wellcome Biotechnology, Beckenham, United King-
dom. A purified monoclonal IgGI fraction of 79-3 was prepared and covalently coupled
to CNBr-Sepharose 4B-CL(Pharmacia Fine Chemicals)as suggested by the manufacturer.
Antibodies linked to Sepharose were washed in wash solution (WS) (0.1 % (vol/vol) Triton
X-100 (Boehringer Mannheim Biochemicals), 38 mM Tris (Sigma Chemical Co., St. Louis,
MO), 100 mM glycine (Schwarz/Mann, Cleveland, OH), pH 7.0), containing NPGB and
leupeptin.
Serum Killing.
￿
LOG and PNA- promastigotes were incubated at 37 ° C for 60 min in
PNHS at final serum concentrations ranging from 25% down to 0.18%. Percent killing
was calculated relative to control samples incubated in heat-inactivated serum (see above).
Killing was assessed by loss of promastigote motility and morphologic changes.
C3 Binding Assay.
￿
Binding of C3 to LOG and PNA" promastigotes during incubation
in PNHS and C8D was determined. Promastigotes, at a final concentration of 5 X 10'
parasites/ml in HBSS2+, were incubated at 37°C in 2.5, 5, 10, and 20% PNHS or 2.5 and
10% C8D to which was added '251-C3. Duplicate 200-Pl aliquots of the mixture were
removed at specific time points and layered over 1 ml of ice-cold HBSS2+ in a 1 .5-ml
microcentrifuge tube and centrifuged in the cold at 12,000 gfor 10 min. The supernatant
was aspirated and 125I-C3 within the pellet of parasites was determined. Total molecules
of C3 bound/parasite was calculated at each time point based on the ratio of ' 25I-C3 to
unlabeled C3 present in each serum dilution, as previously described (19).
C3 Uptake in Mg-EGTA Chelated C8D.
￿
Binding of C3 to LOG and PNA- promastigotes
via only the alternative pathway was determined. C8D serum was initially diluted in ice-
cold HBSS2+ containing 2 mM MgCl2 and 10 mM EGTA and allowed to sit at 0° to 4°C
for 15 min. LOG and PNA- promastigotes at a final concentration of 5 X 10' parasites/ml
were incubated at 37 °C in 10% C8D or 10% Mg-EGTA C8D to which was added '25I-
C3 . Duplicate aliquots were removed at specific time points and were processed as
described above to determine total molecules of C3 bound/parasite.
C3 Fragmentation Pattern. The form of C3 on the parasite surface during serum
incubationwas determined. A totalof 2 X 108 LOG promastigotes or PNA- promastigotes
were incubated for 30 min at 37°C in 20% C8D in HBSS2+ to which was added 125I-C3.890
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The final concentration of parasites was 5 x 10' parasites/ml of reaction mixture. Parasites
were collected by centrifugation at 12,000 g for 5 min in the cold, washed three times in
HBSS21 containing NPGB and leupeptin, and the pellet of parasites was solubilized in 4%
SDS, containing both inhibitors, by boiling at 100°C for 10 min. One-half of the volume
of the SDS-solubilized serum-incubated parasites were brought to 2% SDS, 25 mM
CH,NH2, 100 mM carbonate, pH 11 .0, by the addition of a concentrated stock solution
of methylamine and incubated at 37°C for 60 min. Methylamine treatment was done to
cleave covalent ester linkages between C3 and parasite membrane constituents (20). The
pH was neutralized to approximately pH 7 by the addition of 2-3 A,1 of 5 N HCI, then
samples were solubilized by boiling at 100'C for 10 min in SDS-sample buffer that
contained 2-ME, NPGB and leupeptin. The remaining SDS-solubilized sample not treated
with CH,NH2 was boiled in SDS-sample buffer containing 2-ME and both inhibitors at
100 ° C for 10 min. SDS-PAGE was performed using 10% acrylamide slab gels by the
method of Laemmli (21). Autoradiography was done using Cronex x-ray film (DuPont
Co., Wilmington, DE) with a Quanta III enhancing screen (DuPont Co.).
Analysis ofReleased C3 Fragments.
￿
The C3 fragments released from the parasite surface
after serum incubation were analv,zed by SDS-PAGE autoradiography. 5 x 10' LOG and
5 x 10' PNA- parasites in HBSS + were incubated in 1 ml of 10% C8D serum containing
1251-C3 for 30 min at 37 °C, washed twice in HBSS21 without inhibitors, and resuspended
to the original volume. The mixture was incubated at 37°C. Aliquots were removed at
various time points, centrifuged at 12,000 g for 5 min at 4°C and the supernatant was
removed. Both supernatant and pellet of parasites were solubilized in SDS-sample buffer
containing NPGB, leupeptin, and 2% 2-ME by boiling at 100°C for 10 min. SDS-PAGE
autoradiography was done as described above.
C3cRelease Assay.
￿
The percentageof the Cab and iC3b on the parasite surface during
serum incubation was also determined by an alternative approach. We performed this
analysis using a modification of the method previously described by Gaither et al. (22).
This procedure provides a quantitative method of determining the distribution of mem-
brane-bound Cab and iC3b, based on release by low concentrations of trypsin; iC3b is
sensitive to trypsin proteolysis while C36 is relatively resistant to limiting concentrations
of trypsin. 2 x 108 LOG promastigotes or PNA- promastigotes were incubated for 30
min at 37 °C in 20% C8D in HBSS2+ to which was added "'I-C3 . The final concentration
of parasites was 5 x 10' parasites/ml of reaction mixture. Parasites were collected by
centrifugation at 12,000 g for 5 min at 4°C, washed three times in ice-cold HBSS21
without inhibitors, and resuspended in 1 ml ice-cold HBSS2'. 100 Al of washed serum-
incubated parasites were combined with 100 AI of a dilution of TPCK trypsin (Sigma
Chemical Co., serial fivefold dilution from 2.5 mg/ml to 0.8 jug/ml) prepared in HBSS2+,
and incubated at 30'C for 10 min . 50 Al of ice-cold inhibitor solution containing 16 mg
soybean trypsin inhibitor (Sigma Chemical Co.) per milliliter HBSS2+, 50 AM NPGB, and
2.5 Ag/ml leupeptin was added to inhibit trypsin proteolysis. All samples were then
centrifuged at 12,000 g for 10 min in the cold and the supernatant was immediately
removed. Both pellet and supernatant were solubilized in SDS sample buffer as described
above. 1251-C3 counts in supernatant and pellet were determined and the percent "'I-C3
counts released into the supernatant was calculated. SDS-PAGE autoradiography of the
supernatants was performed as described above.
Determination of C3 Acceptor by Immunoprecipitation.
￿
The molecule to which C3 binds
on LOG and PNA- parasites was determined. Native parasites were incubated in serum
containing 1251-C3, and the extent of precipitation of 1251-C3 from detergent-solubilized
parasites was compared for antibodies directed against the LPG and gp63 . LOG and
PNA- promastigotes were incubated in C8D containing 1251-C3 for 30 min at 37'C at a
final concentration of 5 x 10' parasites/ml. The serum-incubated parasites were washed
twice and the pellet of parasites (2 x 108) that was collected by centrifugation at 12,000 g
for 5 min was solubilized overnight at 4° C in 1 ml of LS (1% vol/vol Triton X-100;
Boehringer Mannheim Biochemicals), 38 mM Tris (Sigma Chemical Co.), 100 mM glycine
(Schwarz/Mann), pH 7 .0, containing NPGB and leupeptin. This lysate was cleared by
centrifugation at 12,000 g for 10 min in the cold and preabsorbed for 4 h with 50 AlPUENTES ET AL .
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FIGURE 1 .
￿
Killing ofLOG andPNA- promastigotes
in normal human serum . LOG (solid line) and PNA-
(broken line) promastigotes at a final concentration of
2 X 10'/ml were incubated for 60 min at 37°C in
dilutions of PNHS ranging downward from 25 to
0.18% . Percent killing was determined by light micro-
scopic assessment ofshape and motility.
(packed volume) Sepharose 4B that had been swelled and washed in lysis solution (LS) .
The lysate was centrifuged at 12,000g for 30 s and the supernatant was removed . 100 A1
(packed volume) of immunoabsorbant 79-3 suspended in WS (0.1% Triton X-100, 38
mM Tris, 100mM glycine, pH 7 .0) was added to a 200-A1 aliquot of cleared lysate that
had been diluted 10-fold with WS containing NPGB and leupeptin, rocked overnight at
VC . C . 25 ul of anti-gp63 or prebleed serum from the same rabbit was added to similarly
prepared samples of cleared LOG and PNA- lysates then rocked for 6 h at 4° C, followed
by the addition of 100 ul (packed volume) of protein A-Sepharose 4B (Pharmacia Fine
Chemicals) and rocked overnight at 4 °C . Total 125I-C3 cpm bound by the immunoabsor-
bants was determined and the percent '2'I-C3 immunoprecipitated calculated relative to
input counts .
Experiments were done using 125I-labeled LOG and PNA- promastigotes to assess the
efficiency of immunoprecipitation by anti-gp63 . 3 X 10 8 LOG and PNA- promastigotes
were 1211 labeled as previously described (23) with 500 jCi'25I-Na (Amersham Corp .) and
incubated in 10% C8D at a final concentration of 5 X 10" parasites/ml for 30 min at
37'C . Lysates were prepared and immunoprecipitated with anti-gp63 and prebleed serum
as described.
The molecular form ofC3 associated with theC3 acceptor that was immunoprecipitated
by 79-3 and anti-C3 was examined by SDS-PAGE autoradiography . Lysates ofLOG and
PNA- promastigotes bearing 12'I-C3 after incubation in C8D serum were prepared and
immunoprecipitated with 100 jAl (packed volume) of 79-3 or anti-C3 immunoabsorbant.
'25I-C3 counts were eluted by boiling at 100°C for 10 min in 110 Al of 4% SDS-sample
buffer containing 2-ME, NPGB, and leupeptin . SDS-PAGE autoradiography was done as
described above .
Results
Serum Killing .
￿
LOG and PNA- promastigotes were examined for their re-
spective sensitivity or resistance to serum killing (Fig. 1) . 100% of LOG promas-
tigotes were killed when incubated in serum dilutions ranging from 3 to 25% .
Below 3% serum concentration, only a fraction of the LOG promastigotes were
killed after incubation for 60 min at 37 0C . This is in contrast to PNA- promas-
tigotes that were partially resistant to serum-mediated killing at serum concen-
trations from 25 to 3%, but completely resistant to serum killing at serum
concentrations of3% or less.
C3 Uptake inPNHS.
￿
Quantitative measurement of the binding ofC3 toLOG892
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and PNA- promastigotes was initially done in kinetic fashion in varying dilutions
of PNHS (Fig. 2) . At 15 min of serum incubation there was substantial binding
of C3 to LOG promastigotes at each serum dilution. Maximum binding of C3 at
each serum dilution was greater for LOG promastigotes than for PNA- promas-
tigotes. Additionally, there was a loss of total molecules of C3 bound to LOG at
30, 60, 90, and 120 min of serum incubation when compared with the 15-min
time point. This spontaneous loss of C3 was substantially greater for LOG than
for PNA- promastigotes. The kinetics of C3 binding to the LOG promastigote
surface correlated with the kinetics of serum killing (not shown). For PNA-, no
killing occurred at 60 min in 3% serum, despite binding of 2 .3 x 105 molecules
C3/parasite in 2 .5% PNHS. In 5% serum, only 20% killing of PNA` promasti-
gotes was achieved at 60 min, despite binding of 4.4 x 105 molecules C3/parasite,
a level that led to 100% killing of LOG promastigotes. These results suggest that
serum resistance in PNA- does not simply reflect inefficient complement acti-
vation.
C3 Uptake in C8D.
￿
A serum source deficient in terminal complement com-
ponent 8 (C8D) was also used to examine the binding of C3 to the surface of the
LOG or PNA- promastigotes. C3 bound rapidly to LOG and PNA- promasti-
gotes with maximal C3 binding occurring at the 15-min time point for the LOG
and at the 90-min point for PNA- when incubated in 2.5% C8D (Fig. 3). In the
absence of an intact terminal complement cascade, no killing was observed for
LOG or PNA- (data not shown), indicating that release of bound C3 was not a
consequence of parasite lysis.
C3 Uptake Via the Alternative Pathway.
￿
Mg-EGTA C8D was used to determine
quantitatively the binding of C3 on LOG and PNA" promastigotes that occurs
via the alternative pathway. As shown in Fig. 4, LOG promastigotes bind C3 in
Mg-EGTA C8D to an extent nearly equivalent to that in nonchelated serum.
There is a lag in the onset of C3 deposition, consistent with activation through
the alternative pathway. In contrast, PNA- promastigotes bind negligible
amounts of C3 during 120 min of incubation in Mg-EGTA C8D, indicating that
PNA- parasites do not activate the alternative pathway in nonimmune serum.
Similar results were obtained when PNHS was used instead of C8D.
Molecular Form of C3.
￿
We analyzed serum-incubated promastigotes bearing
125I-C3 for the molecular form ofC3 . The predominant C3 a' fragment-acceptor
complex on both the LOG and PNA- promastigotes (Fig. 5, - lanes) migrates as
a diffuse band of molecular weight 140-340 x 103 (LOG) and 200-340 x 103
(PNA-). Since the maximum size of the native a' chain of C3b is 110 x 10' mol
wt, this result indicates that C3 binds covalently to a parasite membrane C3
acceptor. Of note, there is a prominent 110 x 103 mol wt band only on the
surface of the PNA- promastigote.
We next analyzed the molecular form of the bound C3 fragments of serum
incubated LOG and PNA- promastigotes after treatment with methylamine, a
nucleophile that cleaves O-ester linkages (Fig. 5, + lanes). The "'I-C3 fragments
generated from LOG and PNA- promastigotes by methylamine treatment mi-
grated at 110 and 68 x 105 mol wt, corresponding to C3b and iC3b, respectively.
The major fragment of C3 after methylamine treatment on both parasites was
110 x 103 mol wt. These experiments show that both LOG and PNA- promas-L
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FIGURE 3. Kinetics of C3 binding to
LOG and PNA- promastigotes in C8D
serum. 5 X 10' LOG (-) promasti-
gotes/ml or 5 X 10' PNA- (- --) pro-
mastigotes/ml were incubated at 37'C
for 120 min in 2.5% C8D containing
1251-C3. Total molecules of C3 bound
perparasite was determined at indicated
time points.
FIGURE 4. Kinetics of C3
binding to LOG and PNA-
promastigotes in C8D serum
and Mg-EGTA C8Dserum. 5
X 10' LOG (O, 9) promasti-
gotes/ml and 5 X 10' PNA-
(A, A) promastigotes/ml were
incubated at 37°C for 120
min in either 10% C8D (-)
or 10% Mg EGTA C8D
(---) containing ' 25I-C3 .
The 10% Mg-EGTA C8D in-
cubation was to limit comple-
ment activation to the alter-
native pathway. Total mole-
cules C3 bound per parasite
was determined at indicated
time points.
tigotes bear predominantly Cab, that before methylamine treatment PNA-
promastigotes bear a large amount of C3 in a molecular form of 110 X 103 mol
wt, and that the majority of C3 that is covalently attached to parasite membrane
C3 acceptors is bound by a cleavable O-ester linkage.
C3c Release Results.
￿
We wanted to confirm the distribution of C3 fragments
on LOG and PNA- parasites using a different approach. Whereas iC3b is sensitive
to proteolysis at low concentrations of trypsin, resulting in release of C3c into
the supernatant, Cab is resistant to proteolysis (22). We found that 0.4 ug/ml of
trypsin released 11 .9% of 1251-C3 from serum-incubated LOG and 15 .0% of the
'251-C3 from the serum-incubated PNA- promastigotes. The expected presence
of the C3c fragment in the trypsin supernatant was confirmed by SDS-PAGE
autoradiography (Fig. 6) in which a 27 X 10' mol wt band corresponding to the
labeled a' fragments of C3c was generated in limiting trypsin dilutions. Also of
note, corroborating results in Fig. 5, is the 110 X 10' mol wt band in the PNA-
pellet but not the LOG pellet. These results confirmed the SDS-PAGE analysis
of bound C3 fragments (Fig. 5), showing that >80% of the C3 on the surface of
both stages of promastigotes is in the form of C3b.
Spontaneous Release of C3.
￿
We next examined the 1251-C3 fragments releasedPUENTES ET AL .
FIGURE 5.
￿
Molecular form of C3 on L . major
promastigotes . LOGand PNA- promastigotes at 5
x 10'/ml were incubated for 30 min at 37°C in
20% C8D containing 1251-C3 . Promastigotes were
washed, then solubilized at 100'C in 4% SDS
containing NPGB and leupeptin . A portion of the
solubilized parasites were then incubated with 25
mM CH3NH2 to cleave covalent O-ester linkages
between C3 and parasite constituents (+ lanes)
before solubilization in SDS-sample buffer. Non-
methylamine-treated parasites (- lanes) were sol-
ubilized directly in SDS-sample buffer . Samples
were analyzed by 10% SDS-PAGE autoradiogra-
phy .
FIGURE 6. SDS-PAGE analysis of 1251-C3 fragments released from serum-incubated LOG
and PNA- promastigotes treated with limiting dilutions of trypsin . 2 x 10' LOG and PNA-
promastigotes were incubated in 20% C8Dthen washed . Aliquots containing 5 X 106 promas-
tigotes were incubated in dilutions of trypsin (0, 0.4,and 2 ug/ml final concentration) . LOG
andPNA- parasite pellets withouttrypsin treatmentandthe supernatants ofthe trypsin treated
LOGandPNA- parasites were analyzed by 10% SDS-PAGE autoradiography under reducing
conditions .
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FIGURE 7.
￿
Spontaneous release of "'I-C3
by L. major promastigotes after incubation
in C8D serum. 5 x 107 LOG and 5 x 107
PNA- promastigotes were incubatedfor 30
min in 10% C8D containing 125I-C3 . The
parasites were washed in HBSS2' and incu-
bated in HBSS4+ for 60 min at 37°C. Per-
cent of total `'I-C3 counts released spon-
taneously into buffer by LOG (-) and
PNA- (- - -) was determined at 0, 30, and
60 min.
from the parasite surface after serum incubation. Parasites bearing 1251-C3 were
washed to remove serum then incubated in HBSS2'' buffer. There was continued
spontaneous release of 1251-C3 by both LOG and PNA- promastigotes after
serum incubation with nearly a threefold greater percentage of release of 1251-
C3 fragments by LOG promastigotes (Fig. 7). Analysis by SDS-PAGE of the '25I-
C3 fragments released into serum-free buffer (Fig. 8, S lanes) revealed the
generation of multiple fragments of '25I-C3 of molecular weight 68, 35, and 25
X 10'. The 68 X 10' mol wt fragment represents the a'-chain of iC3b. The 35
x 103 and 25 X 103 mol wt '25I-C3 fragments are atypical C3 cleavage fragments
when compared with the scheme for physiologic C3 breakdown by factor I and
factor H, or CR124 (reviewed in reference 24). No high molecular weight C3-
acceptor complexes are released into the supernatant and spontaneous release
of intact C3b from the parasite C3 acceptor is negligible. These results show that
release ofC3 from both LOG and PNA- is a consequence ofproteolytic cleavage.
Determination of C3 Acceptor.
￿
Experiments were performed to define the
parasite molecule to which C3 was covalently attached, the C3 acceptor molecule.
Parasites were incubated in serum containing '25I-C3, and the extent of immu-
noprecipitation of 125I-C3 fragments with antiparasite antibodies was determined.
Direct immunoprecipitation of detergent solubilized LOG and PNA- promasti-
gotes bearing 125I-C3 with mAb 79-3, directed against both LOG and PNA-
LPG, showed in five separate experiments that the LPG defined by this mAb is
the major C3 acceptor. Table I shows the data from a representative experiment
in which 79-3 immunoprecipitated 87 .4% and 67 .7% of the covalently attached
125I-C3 to LOG and PNA-, respectively. In contrast, anti-gp63 immunoprecipi-
tated <I I% of labeled C3 on both LOG and PNA- promastigotes. In a control
experiment, the majority of 1251-labeled gp63 was immunoprecipitated under
similar conditions.
The molecular form of C3 fragments immunoprecipitated by 79-3 was exam-
ined by SDS-PAGE autoradiography. The pattern was compared with the frag-
ments recognized by anti-C3 to determine ifa particular subset of C3 fragmentsPUENTES ET AL .
TABLE I
Determination of C3 Acceptor by Immunoprecipitation
"l-C3 counts immunoprecipitated by :
Discussion
FIGURE 8 . SDS-PAGE autoradiogra-
phy of "'I-C3 fragments spontaneously
released from L . major promastigotes
after 60 min of incubation in buffer . 5
X 10 7 LOGand 5 X 107 PNA- promas-
tigotes were incubated for 30 min in
10% C8D containing "°I-C3 . The para-
sites were washed in HBSS" and incu-
bated in HBSS` for 60 min at 37°C .
The form of released C3 andofresidual
bound C3 wasdetermined by 10% SDS-
PAGE autoradiography . P, pellet ; S, su-
pernatant .
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wasassociated with theLPG. The molecular form ofC3 associated with theLPG
(Fig. 9 A) was similar to that on whole parasites (Fig . 5) and to the fragments
immunoprecipitated by anti C3 (Fig . 9 B) . In LOG, the major band immuno-
precipitated with 79-3 wasa high molecularweight C3-acceptorcomplex whereas
ahigh molecular weight C3-acceptorcomplex waspresentalongwithaprominent
a' 110 X 10' mol wt band in PNA-. These results thus indicate that the
fragmentation profile of C3 bound to the LPG acceptor reflects the profile of
total C3 on the parasite surface (Fig . 5) .
We have examined the activation of complement by two developmental stages
of L. major promastigotes : noninfective, serum-sensitive LOG-phase promasti-
gotes and infective, serum-resistant stationary-phase PNA- promastigotes . Quan-
L . major stage
79-3 anti-gp63 Prebleed
%
LOG 87.4 5.7 5.4
PNA- 67.7 10.8 8.7898
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FIGURE 9 .
￿
Determination of the C3 acceptor by SDS-
PAGE analysis of C3 fragments associated with LPG.
Samples of ...I-C3 fragments immunoprecipitated with
anti-LPG mAb 79-3 (A) and anti-human C3 (B) were
solubilized in SDS-sample buffer containing 2-Me and
analyzed by 5-15% SDS-PAGE autoradiography. L,
LOG; P, PNA- . Molwt markers (x 10-') are shown .
titative measurement of the binding of C3 to LOG promastigotes in PNHS and
C8D serum correlates with the kinetics ofserum killing, whereas for PNA=there
is no such correlation . LOG and PNA- promastigotes activate complement
rapidly as determined by '251-C3 binding studies, but a distinction between the
two developmental stages is apparent when the complement pathway being
activated and the molecular form of C3 on the surface are compared . Whereas
LOG parasites activate the alternative pathway efficiently, PNA- forms are totally
incapable of activating the alternative pathway in human serum . Both LOG and
PNA- promastigotes bear primarily hemolytically active Cab on their surface ;
however a 110 x 105 mol wt C3 fragment is found associated only with the
infective PNA- promastigotes . Nonetheless, the major C3 acceptor for both
LOG and PNA- is the LPG . Thus, serum resistance in PNA" promastigotes does
not result from inefficient complement activation through C3 nor a failure to
generate hemolytic C3 fragments on the parasite surface . Instead, changes in the
parasite surface, possibly related to expression of the developmentally regulated
LPG, must affect lytic complement activity at a later step in the cascade .
LOG parasites activated the alternative pathway efficiently in comparison to a
complete absence of alternative pathway activation by PNA- promastigotes . No
analogous observation has been made previously with any Leishmania species .
Earlier studies of complement activation by Leishmania promastigotes have used
either unfractionated or incompletely fractionated parasites to examine the
complement pathway being activated or the extent of C3 deposition . Pearson
and Steigbigel (25) concluded that L . donovani promastigotes activated the
classical pathway inan antibody-dependentmanner . Although subsequent studies
(11) have arrived at the same conclusion, other workers (26, Puentes, S . M ., et
al ., manuscript in preparation) suggested that complement activation occurs via
the alternative pathway by theseforms . In contrast, alternative pathway activation
by unfractionated L . braziliensis panamensis, L . donovani, L . major, and L. mexi-
cana amazonensis has consistently been reported (11, 27) . Our results indicate
that any simple categorization of the complement pathway being activated by a
particular Leishmania species is likely to be inconclusive since different growth
phases of the same strain and species can activate different pathways .PUENTES ET AL .
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We observed a C3 band of 110 X 103 mol wt on PNA- promastigotes but not
on LOG promastigotes before methylamine treatment . This band, which comi-
grates with the native a' 110 X 10' mol wt fragment of C3b, suggests that this
portion of the C3 is not attached covalently to a parasite acceptor molecule .
However, alternative explanations need to be considered . First, the ester linkage
between C3b and acceptor may be less stable on PNA- than on LOG, resulting
in spontaneous cleavage of the C3b-acceptor bond during sample processing
(28) . Prompt boiling of samples in SDS sample buffer, as we have done, should
minimize this possibility . Secondly, C3b may be covalently bound to a low
molecular weight acceptor, such as a phospholipid, which does not appreciably
alter migration of the a' chain by SDS-PAGE . Lastly the 110 X 103 mol wt band
in PNA- could represent the 68 X 103 mol wt fragment of iC3b attached by a
methylamine-resistant linkage to a parasite constituent of-40 X 103 mol wt ; this
seems unlikely however since no change in the intensity of the 110 X 103 mol wt
band occurred in the C3c release assay (not shown) . Thus, the possibility remains
that C3b has an affinity for the surface of metacyclic promastigotes, presumably
via the modified form of the LPG, as if these molecules served as C3 receptors .
Experiments are underway in our laboratory to examine this possibility .
Once C3 has bound to the surface of the L. major promastigote, it has one of
two fates . It either remains associated with the surface of the parasite or is
released spontaneously from the surface of the parasite by a cleavage event . This
latter process may be mediated through an endogenous parasite protease that
cleaves and releases fragments ofC3 from the C3-acceptor . The rate of release
of C3 fragments is nearly threefold greater for LOG promastigotes than for
PNA- promastigotes and may be a reflection of the overall metabolic state of
theLOG promastigotes . The release of proteolytically cleaved C3 fragments was
seen in a similar series of experiments using L . donovani promastigotes (Puentes,
S . M ., et al ., manuscript in preparation) . Since Etges et al . (29) has shown that
the major surface glycoprotein gp63 has protease activity, we are currently
examining whether this is the protease responsible for C3 release .
We show here that C3 binds to the excreted factor expressed on the outer
surface of both LOG and PNA- promastigotes . The importance of the LPG as
a cell attachment antigen has been previously reported by Handman et al . (7-9)
and by Sacks and da Silva (10) . The relationship between the C3 binding and
cell attachment functions of the LPG requires further definition . Of interest,
Russell (30) has shown that gp63 is a major C3 acceptor to L . mexicana, and also
serves as a cell attachment antigen . While our results do not argue that the L .
major LPG is the only acceptor site for C3, quantitative analysis suggests that the
LPG is certainly the predominant acceptor molecule .
The LPG produced by PNA- parasites is developmentally regulated . Sacks
and da Silva (10) have suggested that the addition of a terminal sialic acid on
PNA- LPG alters its migration on SDS-PAGE, enhances labeling of the LPG by
periodate oxidation and borohydride reduction under conditions in which pri-
marily sialic acid is labeled, and blocks the capacity ofPNA to bind to subterminal
galactose residues. The relationship of these biochemical modifications to the
form ofbound C3 and to the release ofC3 from the parasite surface is not clear .
In erythrocytes, the presence of sialic acid is often associated with conversion of900
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C3b to iC3b, an effect we did not see here (30). Nonetheless, it is intriguing that
PNA- promastigotes do not activate the alternative complement pathway (Fig.
5), since sialic acid is known to inhibit alternative pathway activation in other
systems (31).
It now appears that the complement system interacts with different species
and growth phases of Leishmania in quite distinctive manners. These differences
may profoundly influence the macrophage subpopulations and cellular receptors
with which these different species interact. Blackwell et al. (14) and Mosser and
Edelson (16) have previously shown that the iC3b receptor on mononuclear cells,
CR3, plays an important role in the attachment of the L. donovani and L. major
promastigotes to the macrophage. Although we have found that nearly three-
fourths of the C3 bound to L. donovani promastigotes is present as iC3b (Puentes,
S. M ., et al, manuscript in preparation), 80-85% of the C3 bound to L. major
promastigotes is in the form C3b, which binds to CR1 but not CR3 . Furthermore,
opsonized L. majorpromastigotes bind more efficiently and are internalized more
efficiently than unopsonized parasites to cultured mouse (26) or human macro-
phages (da Silva, R., manuscript in preparation); the binding and internalization
of only the PNA- metacyclic can be significantly inhibited by an mAb to CR1
but not monoclonals to CR3 (da Silva, R., et al., manuscript in preparation). This
suggests that CR 1 is important for PNA- metacyclic binding and entry into the
macrophage. These results, which correlate with the studies we have presented
here, provide a framework for further study on the role of complement receptors
for successful cell invasion by L. major promastigotes.
Summary
The binding of complement by two developmentally distinct stages of Leish-
mania major has been studied. Noninfective log phase growth (LOG) promasti-
gotes (serum sensitive) activate complement with deposition of covalently bound
C3b onto the surface of the parasite. Infective, peanut agglutinin (PNA-) meta-
cyclic stage promastigotes (serum resistant) also bear mainly C3b after incubation
in serum, but a major portion of deposited C3 is present as a 110 X 10' mol wt
C3 fragment. Whereas deposition of C3b on LOG promastigotes is mediated
through the alternative pathway, PNA- parasites are unable to activate the
alternative pathway in nonimmune serum. C3 is released from the parasite
surface by proteolytic cleavage, at a rate which is nearly threefold greater for
LOG than for PNA- promastigotes. Immunoprecipitation experiments show that
the developmentally regulated lipophosphoglycan is a major C3 acceptor on both
LOG and PNA- parasites. These experiments, which are the first to compare
the form and processing of complement on infective and noninfective promasti-
gotes ofLeishmania, provide a framework for further definition of the differential
C3 receptor-dependent uptake and survival of these parasites within mononu-
clear phagocytes.
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